{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:05:29Z","timestamp":1790809529641,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54 DK106829"],"award-info":[{"award-number":["U54 DK106829"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-23-2057"],"award-info":[{"award-number":["N00014-23-2057"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-21-1-2954"],"award-info":[{"award-number":["N00014-21-1-2954"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003359","name":"Scoliosis Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA231838"],"award-info":[{"award-number":["CA231838"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI069197"],"award-info":[{"award-number":["AI069197"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA100019"],"award-info":[{"award-number":["CA100019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA218285"],"award-info":[{"award-number":["CA218285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5U24CA076518"],"award-info":[{"award-number":["5U24CA076518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL069294"],"award-info":[{"award-number":["HL069294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtct.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:11:48Z","timestamp":1736424708000},"page":"137-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Association of HLA-E Ligand and NKG2 Receptor Variation With Relapse and Mortality After Haploidentical Related Donor Transplantation"],"prefix":"10.1016","volume":"31","author":[{"given":"Effie W.","family":"Petersdorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2161-8259","authenticated-orcid":false,"given":"Caroline","family":"McKallor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Malkki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-8252","authenticated-orcid":false,"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.01.004_bib0001","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.004_bib0002","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtct.2023.03.007","article-title":"Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.01.004_bib0004","unstructured":"Bolon YT, Atshan R, Allbee-Johnson M, et al. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2022. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx. Accessed 01 September, 2023"},{"key":"10.1016\/j.jtct.2025.01.004_bib0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/bmt.2016.324","article-title":"Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization","volume":"52","author":"Grosso","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.004_bib0006","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jtct.2025.01.004_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0008","unstructured":"The Genotype-Tissue Expression (GTEx) database v8 portal. https:\/\/www.gtexportal.org\/home\/. Accessed February 4, 2022."},{"key":"10.1016\/j.jtct.2025.01.004_bib0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/0008-5472.CAN-05-2776","article-title":"Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance","volume":"66","author":"Hayashi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtct.2025.01.004_bib0010","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1002\/eji.201343773","article-title":"NKG2C zygosity influences CD94\/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus","volume":"43","author":"Muntasell","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0011","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2025.01.004_bib0012","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/aid.2011.0253","article-title":"NKG2C deletion is a risk factor of HIV infection","volume":"28","author":"Thomas","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jtct.2025.01.004_bib0013","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2018.08.008","article-title":"Quantity and quality reconstitution of NKG2A(+) natural killer cells are associated with graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"25","author":"Hu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.004_bib0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-015-0213-y","article-title":"Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts","volume":"34","author":"Picardi","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jtct.2025.01.004_bib0016","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1182\/bloodadvances.2022008952","article-title":"Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT","volume":"7","author":"van der Ploeg","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.01.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110959","article-title":"Primary and secondary functions of HLA-E are determined by stability and confirmation of the peptide-bound complexes","volume":"39","author":"Walters","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtct.2025.01.004_bib0018","unstructured":"IPD-IMGT\/HLA Database, Version 3.55. https:\/\/www.ebi.ac.uk\/ipd\/imgt\/hla\/. Accessed January 2, 2024."},{"key":"10.1016\/j.jtct.2025.01.004_bib0019","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1074\/jbc.M208268200","article-title":"HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities","volume":"278","author":"Strong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtct.2025.01.004_bib0020","doi-asserted-by":"crossref","first-page":"eadm7515","DOI":"10.1126\/sciadv.adm7515","article-title":"CD8+ T cell targeting the tumor antigens presented by HLA-E","volume":"19","author":"Iyer","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtct.2025.01.004_bib0021","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.TP.0000158711.37550.A0","article-title":"Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation","volume":"80","author":"Tamouza","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.01.004_bib0022","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/01.tp.0000244598.92049.dd","article-title":"Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation","volume":"82","author":"Tamouza","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.01.004_bib0023","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/TP.0b013e3181b0e79e","article-title":"Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation","volume":"88","author":"Danzer","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.01.004_bib0024","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/TP.0b013e3181bbb8fe","article-title":"Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors","volume":"88","author":"Ludajic","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.01.004_bib0025","first-page":"15","article-title":"The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Hosseini","year":"2012","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0026","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.leukres.2013.01.011","article-title":"The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Hosseini","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.jtct.2025.01.004_bib0027","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0039.2011.01832.x","article-title":"HLA-E polymorphisms in hematopoietic stem cell transplantation","volume":"79","author":"F\u00fcrst","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jtct.2025.01.004_bib0028","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.humimm.2014.12.017","article-title":"HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients","volume":"76","author":"Mossallam","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0029","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3324\/haematol.2017.169805","article-title":"Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients","volume":"102","author":"Tsamadou","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2025.01.004_bib0030","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2019.03027","article-title":"Decreased soluble human leukocyte antigen E levels in patients after allogeneic hematopoietic stem cell transplantation are associated with severe acute and extended chronic graft-versus-host disease and inferior overall survival","volume":"10","author":"Kordelas","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0031","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.bbmt.2019.08.007","article-title":"Donor HLA-E status associates with disease-free survival and transplant-related mortality after non in vivo T cell-depleted HSCT for acute leukemia","volume":"25","author":"Tsamadou","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.004_bib0032","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1182\/bloodadvances.2022008922","article-title":"Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation","volume":"7","author":"Petersdorf","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.01.004_bib0033","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0034","unstructured":"Allison P. For causal analysis of competing risks, don't use Fine & Gray's subdistribution method. https:\/\/statisticalhorizons.com\/for-causal-analysis-of-competing-risks\/. Accessed August 25, 2024."},{"key":"10.1016\/j.jtct.2025.01.004_bib0035","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fimmu.2018.00389","article-title":"Potential beneficial effects of cytomegalovirus infection after transplantation","volume":"9","author":"Litjens","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149120","article-title":"Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation","volume":"7","author":"Yu","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2025.01.004_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.935949","article-title":"CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire","volume":"13","author":"Hassan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0039","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2009-07-229740","article-title":"NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation","volume":"115","author":"Bj\u00f6rklund","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00005-011-0137-y","article-title":"Clinical significance of the HLA-E and CD94\/NKG2 interaction","volume":"59","author":"Iwaszko","year":"2011","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jtct.2025.01.004_bib0041","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3389\/fimmu.2018.02444","article-title":"Donor NKG2C copy number: an independent predictor for CMV reactivation after double cord blood transplantation","volume":"9","author":"Cao","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0042","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/iji.12523","article-title":"Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells","volume":"48","author":"Bogunia-Kubik","year":"2021","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jtct.2025.01.004_bib0043","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3390\/ijms17111797","article-title":"The activating NKG2C receptor is significantly reduced in NK cells after allogeneic stem cell transplantation in patients with severe graft-versus-host disease","volume":"17","author":"Kordelas","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtct.2025.01.004_bib0044","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4049\/jimmunol.169.1.239","article-title":"Genetic control of human NK cell repertoire","volume":"169","author":"Shilling","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0046","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2002-08-2568","article-title":"Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation","volume":"101","author":"Shilling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.004_bib0047","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4049\/jimmunol.1501434","article-title":"Naive donor NK cell repertoires associated with less leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"196","author":"Bj\u00f6rklund","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1442783","article-title":"Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies","volume":"15","author":"Weitzen","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2695396","article-title":"Characteristics of HLA-E restricted T-cell responses and their role in infectious diseases","author":"Joosten","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtct.2025.01.004_bib0050","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jtct.2025.01.004_bib0051","doi-asserted-by":"crossref","first-page":"144ra101","DOI":"10.1126\/scitranslmed.3003974","article-title":"MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation","volume":"4","author":"Petersdorf","year":"2012","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.jtct.2025.01.004_bib0052","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2352-3026(19)30208-X","article-title":"Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study","volume":"7","author":"Petersdorf","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0053","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molimm.2004.01.004","article-title":"Human NKG2F is expressed and can associate with DAP12","volume":"41","author":"Kim","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0054","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.2017.77.6534","article-title":"Patient HLA germline variation and transplant survivorship","volume":"36","author":"Petersdorf","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.01.004_bib0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2025.01.004_bib0056","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/tan.14231","article-title":"Complete genomic characterization of a new KLRC2 allele, NKG2C*03","volume":"98","author":"Asenjo","year":"2021","journal-title":"HLA"},{"key":"10.1016\/j.jtct.2025.01.004_bib0057","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4049\/jimmunol.1400556","article-title":"Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12","volume":"193","author":"Orbelyan","year":"2014","journal-title":"J Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:00:16Z","timestamp":1778922016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666636725000053"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.004","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of HLA-E Ligand and NKG2 Receptor Variation With Relapse and Mortality After Haploidentical Related Donor Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}